Regulatory Sandboxes in Healthcare

Introduction

A regulatory sandbox in healthcare is a controlled environment in which innovative medical products, digital-health services, diagnostic tools or healthcare technologies are tested under regulatory supervision. It enables regulators to evaluate new technologies while protecting patients from unreasonable risks.

Healthcare sandboxes may involve telemedicine platforms, artificial intelligence-based diagnosis, wearable medical devices, remote patient monitoring, digital therapeutics and novel clinical-care models. Unlike ordinary commercial testing, a healthcare sandbox operates within defined conditions relating to patient eligibility, informed consent, data protection, safety monitoring and regulatory reporting.

The central legal challenge is balancing innovation with the protection of life, health, privacy and patient autonomy. A sandbox may permit limited regulatory flexibility, but it does not automatically suspend healthcare laws or remove liability for harm.

Legal Framework in India

India’s healthcare sandbox ecosystem includes the Ayushman Bharat Digital Mission (ABDM) Sandbox, which enables health technology developers to test integration with digital-health infrastructure in a controlled environment. The framework covers technologies such as teleconsultation, personal health records, e-pharmacy services, health-cloud systems and clinical decision-support tools. Testing periods are generally limited and defined by the programme.

National Housing Authority+1

Healthcare sandboxes must operate alongside existing legislation, including:

Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017 — govern medical devices, including software-based devices, according to their intended purpose and risk classification.

CDSCO+1

Digital Personal Data Protection Act, 2023 — relevant to lawful processing and protection of digital personal data, subject to its applicable provisions and commencement.

Consumer Protection Act, 2019 — may apply where healthcare services or products fall within consumer law.

Clinical-trial and research requirements — apply where testing constitutes regulated clinical research, rather than merely technical integration or simulation.

Sandbox participation does not itself grant marketing authorisation, clinical-trial permission or immunity from liability. In 2026, the Government also stated that AI-enabled medical devices remain subject to the Medical Devices Rules, including technical documentation, risk analysis, validation and clinical evidence requirements.

Press Information Bureau

Relevant Case Laws

1. Samira Kohli v. Dr. Prabha Manchanda, (2008) 2 SCC 1

The Supreme Court held that medical consent must be real and valid: voluntary, given by a competent person and based on adequate information about the procedure, its benefits, alternatives and substantial risks. Applied to healthcare sandboxes, patients must be informed that a technology is experimental or being tested and understand material risks before participating.

Indian Kanoon+1

2. Jacob Mathew v. State of Punjab, (2005) 6 SCC 1

The Supreme Court explained the principles governing medical negligence and the standard of care expected from medical professionals. A healthcare sandbox does not remove the duty to exercise appropriate professional care. However, an adverse outcome alone does not establish negligence; the relevant standard and evidence must be assessed.

3. Jacob Puliyel v. Union of India, 2022 SCC OnLine SC 533

The Supreme Court considered vaccine safety and regulatory decision-making during the COVID-19 pandemic. It recognised the importance of scientific evidence, public-health assessment and patient autonomy. The judgment is relevant by analogy to healthcare sandboxes, where regulators must balance innovation with safety and informed choice.

4. Yash Charitable Trust v. Union of India, judgment dated 30 January 2026

The Supreme Court considered experimental stem-cell interventions for autism and the requirements of valid informed consent. It emphasised that a patient’s consent does not make an unproven treatment lawful or establish its safety and efficacy. The Court distinguished regulated clinical research from the provision of unproven therapy as ordinary medical treatment. This is particularly relevant to healthcare sandboxes involving experimental interventions.

Sci API+1

Conclusion

Healthcare regulatory sandboxes can promote innovation by allowing controlled testing of new medical technologies. Their legitimacy depends on patient protection, informed consent, scientific validation, data security and continued regulatory supervision. They are not exemptions from ordinary healthcare law. The governing principle is innovation under controlled conditions, with patient safety and legal accountability remaining paramount.